Michael LaBarre
Chief Tech/Sci/R&D Officer bei HALOZYME THERAPEUTICS, INC.
Vermögen: 7 Mio $ am 31.03.2024
Profil
Michael J. LaBarre ist Chief Technical Officer & Senior Vice President bei Halozyme Therapeutics, Inc. In seiner früheren Laufbahn hatte Dr. LaBarre die Position des Director-Analytical & Protein Biochemistry bei Biogen, Inc. und des Director-Analytical & Formulation Sciences bei IDEC Pharmaceuticals Corp. (eine Tochtergesellschaft von Biogen, Inc.) und Vice President-Produktentwicklung bei Paramount BioSciences LLC. Dr. LaBarre promovierte an der University of Arizona und erwarb einen Bachelor-Abschluss an der Stony Brook University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2024 | 168 176 ( 0,13% ) | 7 Mio $ | 31.03.2024 |
Aktive Positionen von Michael LaBarre
| Unternehmen | Position | Beginn |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Ehemalige bekannte Positionen von Michael LaBarre
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.04.2006 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01.12.2003 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Ausbildung von Michael LaBarre
| Stony Brook University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
